clinical trials for glp-1 obesity meds actively recruiting 📣 NOW RECRUITING: New Research Study We are looking participants for a Phase 3 trial evaluating a new weight-management option! If you've been on a stable (either Wegovy or Pharmacology Consult: GLP-1 receptor agonists

Your prescription ships discreetly with supplies

Young JM et al (2001): Mecamylamine: new therapeutic uses and toxicity/risk profile

Together, these mechanisms explain how one peptide can address tendons, muscles, gut lining, nerves, and skin

A lengthened synthetic version of insulin-like growth factor 1, carrying an extra amino-acid extension and a single substitution, IGF-1 LR3 is studied as a long-acting growth factor analogue

Srivastava and Ali say those findings generally align with what they see in practice

A new plan to lower the price of GLP-1s The Trump administration announced in early November that it had struck a deal with leading GLP-1 pharmaceutical manufacturers, Eli Lilly and Novo Nordisk, to lower consumer prices for GLP-1 medications